Gb. Cassano et al., THE PANIC AGORAPHOBIC SPECTRUM - A DESCRIPTIVE APPROACH TO THE ASSESSMENT AND TREATMENT OF SUBTLE SYMPTOMS, The American journal of psychiatry, 154(6), 1997, pp. 27-38
Objective: Psychiatric classification is still a topic of considerable
discussion and debate in spite of major advances in the past two deca
des. The debate involves categorical versus dimensional approaches, cu
toff numbers of symptoms to define a case, degree of impairment, objec
tive diagnostic criteria versus more theoretically based criteria, epi
sodic versus trait-like symptoms, and the role of atypical and subclin
ical symptoms. All of these issues have been raised for the anxiety di
sorders and depression. This article presents the conceptualization of
a relatively novel and testable approach to the diagnosis and classif
ication of panic and agoraphobia, the panic-agoraphobic spectrum, and
pilot data on a new questionnaire to assess it. Method: Pilot testing
of the Panic-Agoraphobic Spectrum Questionnaire was undertaken with 10
0 inpatients who had lifetime diagnoses of panic disorder, unipolar de
pression, comorbid panic and unipolar depressive disorders, or an eati
ng disorder. The instrument emphasizes impairment related to 144 behav
iors and experiences in seven panic-agoraphobic symptom domains. Resul
ts: Patients with panic disorder scored highest on the questionnaire,
and those with comorbid depression showed even greater severity of ill
ness. The scores of the patients with eating disorders and of the depr
essed patients differed from those of the other groups but also differ
ed from 0. Conclusions: The spectrum model of panic and agoraphobia is
a flexible and comprehensive means of describing this clinical comple
x. The proposed model, complementary to the categorical approach, pres
umably expresses a unitary pathophysiology. Its usefulness is discusse
d in terms of its value for patient-therapist communication, outcome m
easures, identification of subtle personality traits, and subtyping of
patients for research and treatment.